BRIEF published on 04/02/2024 at 15:05, 7 months 18 days ago Edesa Biotech participera aux prochaines conférences d'investisseurs Immunothérapie Essais Cliniques Produits Biopharmaceutiques Edesa Biotechnologie Conférences Investisseurs
PRESS RELEASE published on 04/02/2024 at 15:00, 7 months 18 days ago Edesa Biotech to Participate in Upcoming Investor Conferences Edesa Biotech, Inc. announces participation in upcoming investor conferences in Toronto, London, and New York to present innovative treatments for immuno-inflammatory diseases Clinical-stage Biopharmaceutical Company Immuno-inflammatory Diseases Investor Conferences Edesa Biotech Inc. Therapeutics
BRIEF published on 03/21/2024 at 21:35, 7 months 30 days ago Edesa Biotech participera à la conférence HC Wainwright sur les maladies auto-immunes et inflammatoires Maladies Inflammatoires Edesa Biotechnologie Conférence Auto-immune Discussion Au Coin Du Feu Produits Biopharmaceutiques Au Stade Clinique
BRIEF published on 03/21/2024 at 21:35, 7 months 30 days ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference Fireside Chat Edesa Biotech Inflammatory Diseases Autoimmune Conference Clinical-Stage Biopharmaceutical
PRESS RELEASE published on 03/21/2024 at 21:30, 7 months 30 days ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference Edesa Biotech to participate in H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference. Fireside Chat with CEO Par Nijhawan, MD and analyst scheduled for March 28, 2024 Fireside Chat Edesa Biotech H.C. Wainwright Autoimmune & Inflammatory Disease Par Nijhawan
BRIEF published on 03/07/2024 at 14:50, 8 months 13 days ago Edesa Biotech to Showcase at Barclays Global Healthcare Conference Clinical Trials Edesa Biotech Immunotherapy Barclays Healthcare Conference ARDS
BRIEF published on 03/07/2024 at 14:50, 8 months 13 days ago Edesa Biotech sera présent à la conférence Barclays Global Healthcare Immunothérapie Essais Cliniques Edesa Biotechnologie Conférence Barclays Sur La Santé SDRA
PRESS RELEASE published on 03/07/2024 at 14:45, 8 months 13 days ago Edesa Biotech to Participate in Barclays Global Healthcare Conference Edesa Biotech, Inc. (NASDAQ:EDSA) to participate in Barclays 26th Annual Global Healthcare Conference in Miami. Company focuses on developing host-directed therapeutics for immuno-inflammatory diseases Biopharmaceutical Company Edesa Biotech NASDAQ:EDSA Barclays 26th Annual Global Healthcare Conference Immune-related Diseases
BRIEF published on 03/04/2024 at 22:35, 8 months 16 days ago Edesa Biotech participera aux prochaines réunions de dermatologie Biopharmaceutique Essais Cliniques Edesa Biotechnologie Dermatologie Maladies Immuno-inflammatoires
BRIEF published on 03/04/2024 at 22:35, 8 months 16 days ago Edesa Biotech to Participate in Upcoming Dermatology Meetings Immuno-inflammatory Diseases Clinical Trials Biopharmaceutical Edesa Biotech Dermatology
Published on 11/21/2024 at 10:03, 1 hour 27 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 30 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 30 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 55 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 11 hours 5 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 11:01, 29 minutes ago Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 30 minutes ago First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 33 minutes ago ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 1 hour 25 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 06:58, 4 hours 32 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 32 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 32 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 22 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 10 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
